Galmed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -74 | -9 | -17 | |
EBITDA | -1,148 | -1,392 | -1,460 | |
EBIT | -1,222 | -1,401 | -1,477 | |
Net Income | -1,119 | -1,275 | -2,016 | -1,473 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,016 | -1,830 | -898 | -2,177 |
Cash | 1,955 | 1,580 | 2,861 | 1,482 |
Basic Shares | 524 | 5,460 | 420 | 6,246 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -31 | -35 | -42 | -39 |
EBITDA | -7,461 | -17,126 | -32,839 | -30,171 |
EBIT | -7,492 | -17,161 | -32,881 | -30,210 |
Net Income | -6,912 | -18,571 | -31,948 | -27,610 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,137 | -18,505 | -32,903 | -26,331 |
Cash | 2,978 | 2,016 | 2,884 | 6,947 |
Basic Shares | 230 | 1,676 | 1,639 | 1,418 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$2.13 |
2024-03-31 | -$0.98 |
2023-12-31 | -$0.98 |
2023-09-30 | -$0.24 |
